GNRH1 and coronary artery disorder: The study found GnRH agonists to be associated with an increased incidence of diabetes (HR, 1.44; p < 0.001), coronary heart disease (HR, 1.16; p < 0.001), myocardial infarction (HR, 1.11; p = 0.03), and sudden cardiac death (HR, 1.16; p = 0.004).